AMYLIN PHARMACEUTICALS INC Stock or Unit Option Plan Expense
AMYLIN PHARMACEUTICALS INC reported Stock or Unit Option Plan Expense of $16.53 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2012-02-22
- AMYLIN PHARMACEUTICALS INC stock or unit option plan expense for fiscal 2011 was $16.53M, a 16.26% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC stock or unit option plan expense for fiscal 2010 was $19.73M, a 2.11% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC stock or unit option plan expense for fiscal 2009 was $20.16M.
| Period end | Stock or Unit Option Plan Expense 12 month |
|---|---|
| 2011-12-31 | $16.53M 10-K · filed 2012-02-22 |
| 2010-12-31 | $19.73M 10-K · filed 2012-02-22 |
| 2009-12-31 | $20.16M 10-K · filed 2012-02-22 |